'+pages+''); $('.stream > div:odd').addClass('bgr_color'); updateHeight('#history'); }); window.activateTabArea = ensure(function(tab, areas){ var parsed = false; var parts = (areas || '').split('/'); window.fsonload = $.inArray('fs', parts) >= 0; if(fsonload){ parts.splice(parts.indexOf('fs'), 1); } var replayMode = false; if($.inArray('replay', parts)>=0){ replayMode = 'replay'; } var noSoundMode = false; if($.inArray('nosound', parts)>=0){ noSoundMode = 'nosound'; } if($.inArray('ns', parts)>=0){ noSoundMode = 'ns'; } var previewMode = null; if($.inArray('p', parts)>=0){ previewMode = 'p'; } if($.inArray('preview', parts)>=0){ previewMode = 'preview'; } if($.inArray('repeat', parts)>=0){ replayMode = 'repeat'; } if($.inArray('r', parts)>=0 || $.inArray('ro', parts)>=0){ replayMode = 'r'; } if(replayMode){ parts.splice(parts.indexOf(replayMode), 1); } if(noSoundMode){ parts.splice(parts.indexOf(noSoundMode), 1); } if(previewMode){ parts.splice(parts.indexOf(previewMode), 1); } if(previewMode){ if(!parts.length){ parts = ['1-14', '999:59']; } } var area = parts[0]; if(tab == 'history' && false){ var page = parseInt(area || '1') || 1; $.ajax({ url: 'https://login.wn.com/recent/json/?pp='+history_pp+'&skip='+history_pp*(page-1), dataType: 'jsonp', success: function(response){ $ensure(function(){ renderHistory(response, page); }); } }); return true; } if(tab == 'global_history' && false){ var page = parseInt(area || '1') || 1; globalHistory.fetchStream(page, '', function(){ updateHeight('#global_history'); }); return true; } if(tab == 'my_playlists' && false){ var page = parseInt(area || '1') || 1; myPlaylists.fetchStream(page, '', function(){ updateHeight('#my_playlists'); }); return true; } if(tab == 'my_videos' && false){ var page = parseInt(area || '1') || 1; myVideos.fetchStream(page, '', function(){ updateHeight('#my_videos'); }); return true; } if(tab == 'related_sites' && areas && matchPosition(areas)){ var seconds = parsePosition(areas); scrollRelated(seconds); return false; } if(matchPosition(area) || matchAction(area)){ parts.unshift('1'); area = parts[0]; } if(tab == 'expand' && area && area.match(/\d+/)) { var num = parseInt(area); if(num < 100){ //FIX ME. Load news page with ajax here } else if(num > 1900){ //FIX ME. Load timeline page with ajax here } } else if(tab.match(/^playlist\d+$/)){ var playerId = parseInt(tab.substring(8)); var vp = videoplayers[playerId]; window.descriptionsholder = $('.descriptionsplace'); if(!vp) return; // why? no player? if(replayMode){ $('.replaycurrent'+playerId).attr('checked', true); vp.setReplayCurrent(true); } var playQueue = []; window.playQueue = playQueue; var playQueuePosition = 0; var playShouldStart = null; var playShouldStop = null; var parseList = function(x){ var items = x.split(/;|,/g); var results = []; for (i in items){ try{ var action = parseAction(vp, items[i]); if(!action.video){ if(window.console && console.log) console.log("Warning: No video for queued entry: " + items[i]); }else{ results.push(action); } }catch(e){ if(window.console && console.log) console.log("Warning: Can''t parse queue entry: " + items[i]); } } return results; }; var scrollToPlaylistPosition = function(vp){ var ppos = vp.getPlaylistPosition(); var el = vp.playlistContainer.find('>li').eq(ppos); var par = el.closest('.playlist_scrollarea'); par.scrollTop(el.offset().top-par.height()/2); } var updateVolumeState = function(){ if(noSoundMode){ if(noSoundMode == 'turn-on'){ clog("Sound is on, vsid="+vp.vsid); vp.setVolumeUnMute(); noSoundMode = false; }else{ clog("Sound is off, vsid="+vp.vsid); vp.setVolumeMute(); noSoundMode = 'turn-on'; } } } var playQueueUpdate = function(){ var playPosition = playQueue[playQueuePosition]; vp.playFromPlaylist(playPosition.video); scrollToPlaylistPosition(vp); playShouldStart = playPosition.start; playShouldStop = playPosition.stop; }; var playQueueAdvancePosition = function(){ clog("Advancing play position..."); playQueuePosition ++; while(playQueuePosition < playQueue.length && !playQueue[playQueuePosition].video){ playQueuePosition ++; } if(playQueuePosition < playQueue.length){ playQueueUpdate(); }else if(vp.getReplayCurrent()){ playQueuePosition = 0; playQueueUpdate(); vp.seekTo(playShouldStart); vp.playVideo(); }else{ vp.pauseVideo(); playShouldStop = null; playShouldStart = null; } }; function loadMoreVideos(playerId, vp, start, finish, callback){ var playlistInfo = playlists[playerId-1]; if(playlistInfo.loading >= finish) return; playlistInfo.loading = finish; $.ajax({ url: '/api/upge/cheetah-photo-search/query_videos2', dataType: 'json', data: { query: playlistInfo.query, orderby: playlistInfo.orderby, start: start, count: finish-start }, success: function(response){ var pl = vp.getPlaylist().slice(0); pl.push.apply(pl, response); vp.setPlaylist(pl); callback(); } }); } if(parts.length == 1 && matchDash(parts[0])){ var pl = vp.getActualPlaylist(); var vids = parseDash(parts[0]); parts = []; for(var i = 0; i < vids.length; i++){ playQueue.push({ 'video': pl[vids[i]-1], 'start': 0, 'stop': null }) } if(vids.length){ if(vids[vids.length-1]-1>=pl.length){ loadMoreVideos(playerId, vp, pl.length, vids[vids.length-1], function(){ if(fsonload){ activateTabArea(tab, parts[0]+'/fs'); }else{ activateTabArea(tab, parts[0]); } var pls = vp.getPlaylist(); vp.playFromPlaylist(pls[pls.length-1]); vp.playVideo(); scrollToPlaylistPosition(vp); }); return true; } } if(playQueue){ playQueueUpdate(); vp.playVideo(); parsed = true; playShouldStart = 0; } } if(previewMode){ var vids = []; var dur = 0; var pl = vp.getActualPlaylist(); area = parts[0]; if(parts.length == 1 && matchPosition(parts[0])){ vids = parseDash('1-'+pl.length); dur = parsePosition(parts[0]); parts = []; }else if(parts.length == 1 && matchDash(parts[0])){ vids = parseDash(parts[0]); dur = parsePosition("999:59"); parts = []; } if(parts.length == 2 && matchDash(parts[0]) && matchPosition(parts[1])){ vids = parseDash(parts[0]); dur = parsePosition(parts[1]); parts = []; } for(var i = 0; i < vids.length; i++){ playQueue.push({ 'video': pl[vids[i]-1], 'start': 0, 'stop': dur }) } if(playQueue){ playQueueUpdate(); vp.playVideo(); parsed = true; } } if(parts.length>1){ for(var i = 0; i < parts.length; i++){ var sel = findMatchingVideo(vp, parts[i]); if(sel){ playQueue.push({ 'video': sel, 'start': 0, 'stop': null }) } } if(playQueue){ playQueueUpdate(); vp.playVideo(); parsed = true; } }else if(area){ var sel = findMatchingVideo(vp, area); if(sel){ vp.playFromPlaylist(sel); playShouldStart = 0; parsed = true; } } if(fsonload || replayMode){ playShouldStart = 0; } if(document.location.search.match('at=|queue=')){ var opts = document.location.search.replace(/^\?/,'').split(/&/g); for(var o in opts){ if(opts[o].match(/^at=(\d+:)?(\d+:)?\d+$/)){ playShouldStart = parsePosition(opts[o].substr(3)) } if(opts[o].match(/^queue=/)){ playQueue = parseList(opts[o].substr(6)); if(playQueue){ playQueuePosition = 0; playQueueUpdate(); } } } } if(matchPosition(parts[1])){ playShouldStart = parsePosition(parts[1]); parsed = true; } if(matchAction(parts[1])){ var action = parseAction(vp, area+'/'+parts[1]); playShouldStart = action.start; playShouldStop = action.stop; parsed = true; } if(playShouldStart !== null && !playQueue.length){ playQueue.push({ video: vp.getCurrentVideo(), start: playShouldStart, stop: playShouldStop }); } if(playShouldStart != null){ setInterval(function(){ if(playShouldStop && vp.currentPlayer && vp.currentPlayer.getCurrentTime() > playShouldStop){ playShouldStop = null; if(vp.getCurrentVideo() == playQueue[playQueuePosition].video){ playQueueAdvancePosition(); }else{ playShouldStart = null; } } }, 500); vp.playerContainer.bind('videoplayer.player.statechange', function(e, state){ if(state == 'ended'){ // advance to the next video playQueueAdvancePosition(); } }); vp.playerContainer.bind('videoplayer.player.readychange', function(e, state){ if(state){ updateVolumeState(); if(playShouldStart !== null){ vp.seekTo(playShouldStart); playShouldStart = null; }else{ playShouldStop = null; // someone started other video, stop playing from playQueue } } if(fsonload) { triggerFullscreen(playerId); fsonload = false; } }); } } else if(tab.match(/^wiki\d+$/)){ if(firstTimeActivate){ load_wiki($('#'+tab), function(){ if(area){ var areaNode = $('#'+area); if(areaNode.length>0){ $('html, body').scrollTop(areaNode.offset().top + 10); return true; } } }); } } return parsed; }) window.activateTab = ensure(function(tab, area){ window.activeArea = null; if(tab == 'import_videos'){ if(area){ import_videos(area); }else{ start_import(); } return true; } if(tab == 'chat'){ update_chat_position($('.chat').eq(0)); window.activeArea = 'chat'; jQuery('.tabtrigger').offscreentabs('activateTab', 'chat'); return true; } if(tab in rev_names){ tab = rev_names[tab]; } if(tab.match(':')){ return false; } var sup = $('ul li a[id=#'+tab+']'); if(sup && sup.length>0){ window.activeArea = area; sup.first().click(); if(!window.activateTabArea(tab, area)){ window.activeArea = null; } window.activeArea = null; return true; }else{ var have_tabs = $('#playlist_menu li').length; if(tab.match(/^playlists?\d+$/)){ var to_add = +tab.substring(8).replace(/^s/,'')-have_tabs; if(to_add>0 && have_tabs){ add_more_videos(to_add); return true; } } } return false; }); window.currentPath = ensure(function(){ return window.lastHistory.replace(basepath, '').split('?')[0]; }); window.main_tab = window.main_tab || 'videos'; window.addHistory = ensure(function(path){ if(window.console && console.log) console.log("Adding to history: "+path); if(window.history && history.replaceState && document.location.hostname.match(/^(youtube\.)?(\w{2,3}\.)?wn\.com$/)){ if(path == main_tab || path == main_tab+'/' || path == '' || path == '/') { path = basepath; } else if( path.match('^'+main_tab+'/') ){ path = basepath + '/' + path.replace(main_tab+'/', '').replace('--','/'); } else { path = basepath + '/' + path.replace('--','/'); } if(document.location.search){ path += document.location.search; } if(window.lastHistory) { history.pushState(null, null, path); } else if(window.lastHistory != path){ history.replaceState(null, null, path); window.lastHistory = path; } } else{ path = path.replace('--','/'); if(path == main_tab || path == main_tab+'/' || path == '' || path == '/') { path = ''; } if(window.lastHistory != '/'+path){ window.location.hash = path? '/'+path : ''; window.lastHistory = '/'+path; } } }); $('.tabtrigger li a').live('click', ensure(function() { var tab = $(this).attr('id'); if(tab.substring(0,1) == '#'){ var name = tab.substring(1); if(name in menu_names){ name = menu_names[name][0]; } realTab = rev_names[name]; $('#'+realTab).show(); if(window.console && console.log) console.log("Triggering tab: "+name+(window.activeArea?" activeArea="+window.activeArea:'')); var path = name; if(window.activeArea){ path = path + '/' + window.activeArea; } if(tab.match(/#playlist\d+/) || tab.match(/#details\d+/)){ $('.multiple-playlists').show(); $('.related_playlist').show(); $('.longest_videos_playlist').show(); }else { $('.multiple-playlists').hide(); $('.related_playlist').hide(); $('.longest_videos_playlist').hide(); } // start the related script only when the tab is on screen showing if (tab.match(/related_sites/)) { if (mc) { mc.startCredits(); } } window.activeTab = realTab; addHistory(path); setTimeout(ensure(function(){ if(tab.match(/language--/)){ $('.tabtrigger').offscreentabs('activateTab', 'language'); } if(tab.match(/weather/)) { $('.tabtrigger').offscreentabs('activateTab', 'weather'); loadContinent(); } updateMenus(tab); updateHeight(); }), 10); } return false; })); }); -->

Idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and ultimately fatal disease characterized by a progressive decline in lung function. The term pulmonary fibrosis means scarring of lung tissue and is the cause of worsening dyspnea (shortness of breath). Fibrosis is usually associated with a poor prognosis.

IPF belongs to a large group of more than 200 lung diseases known as interstitial lung diseases (ILDs), characterized by the involvement of lung interstitium. The interstitium, the tissue between the air sacs in the lung, is the primary site of injury in ILDs. However, these disorders frequently affect not only the interstitium, but also the airspaces, peripheral airways, and vessels. Lung tissue from people with IPF shows a characteristic histopathologic pattern known as usual interstitial pneumonia (UIP). UIP is therefore the pathologic counterpart of IPF. The term 'idiopathic' is used because the cause of pulmonary fibrosis is still unknown. IPF usually occurs in adult individuals of between 50 and 70 years of age, particularly those with a history of cigarette smoking, and affects more men than women. The diagnosis of IPF requires exclusion of other known causes of ILDs and the presence of a typical radiological pattern identified through high resolution computed tomography (HRCT). In the right clinical setting, it is possible to make the diagnosis of IPF by HRCT alone, obviating the need for surgical lung biopsy.

Pulmonary fibrosis

Pulmonary fibrosis (literally "scarring of the lungs") is a respiratory disease in which scars are formed in the lung tissues, leading to serious breathing problems. Scar formation, the accumulation of excess fibrous connective tissue (the process called fibrosis), leads to thickening of the walls, and causes reduced oxygen supply in the blood. As a consequence patients suffer from perpetual shortness of breath.

In some patients the specific cause of the disease can be diagnosed, but in others the probable cause cannot be determined, a condition called idiopathic pulmonary fibrosis. There is no known cure for the scars and damage in the lung due to pulmonary fibrosis.

Signs and symptoms

Symptoms of pulmonary fibrosis are mainly:

  • Shortness of breath, particularly with exertion
  • Chronic dry, hacking coughing
  • Fatigue and weakness
  • Chest discomfort including chest pain
  • Loss of appetite and rapid weight loss
  • Pulmonary fibrosis is suggested by a history of progressive shortness of breath (dyspnea) with exertion. Sometimes fine inspiratory crackles can be heard at the lung bases on auscultation. A chest x-ray may or may not be abnormal, but high-resolution CT will frequently demonstrate abnormalities.

    Podcasts:

    • Idiopathic Pulmonary Fibrosis - pathophysiology, signs and symptoms, investigation and treatment

      "Idiopathic pulmonary fibrosis is a chronic progressive fibrotic interstitial lung disease of unknown cause that primarily occurs in older adults. Doctors suspect interstitial lung disease when an adult presents with unexplained exertional dyspnoea, chronic dry cough or inspiratory velcro-like crackles on examination. Fibrosis is typically in the lower lobes of the lung. Clubbing , low oxygen saturation and dyspnoea is the hallmark of idiopathic pulmonary fibrosis. High resolution CT chest is cold standard for diagnosis. Here you see the pathological pattern of usual interstitial pneumonia: low base predominance, traction bronchiectasis, honeycombing and reticular changes without significance ground glass changes" Support me: 🖼️ Buy PDFs: http://armandoh.org/shop 💵 Patreon: http://www.p...

      published: 21 Aug 2021
    • Idiopathic Pulmonary Fibrosis | Restrictive Lung Disease | Pulmonology

      😍🖼Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/ - With Picmonic, get your life back by studying less and remembering more. Medical and Nursing students say that Picmonic is the most comprehensive and effective way to bridge learning and test prep... Disclaimer: I use affiliate links.... ►👨‍🏫💊Antibiotics Lectures: https://www.medicosisperfectionalis.com/products/courses/antibiotics/ ... Check out my brand new "Electrolytes" course at https://www.medicosisperfectionalis.com/products/course/electrolytes/ and use the PROMO code: ELECTROLYTES50 to get a 50% discount. If you like my videos, please consider leaving a tip at https://www.paypal.me/perfectionalis/ ► Visit my website: https://www.medicosisperfectionalis.com/ My Favorite Productivity App: https://...

      published: 26 Sep 2019
    • Signs & Symptoms of Idiopathic Pulmonary Fibrosis (IPF)

      published: 07 Sep 2017
    • Introduction into idiopathic pulmonary fibrosis (IPF)

      Idiopathic pulmonary fibrosis (or IPF) is a life-threatening lung disease. The pathophysiology of this condition is not fully understood, though it is believed to arise through successive injury to the alveolar epithelial cell compartment.

      published: 29 Nov 2016
    • Idiopathic Pulmonary Fibrosis: Bills Story

      Bill Van Nierop, who lives with Idiopathic Pulmonary Fibrosis (IPF), defines himself as an IPF patient not an IPF sufferer. Bill talks about the stigma surrounding lung disease, the impact this has on research and his goal to to help others living with a lung disease through raising awareness and changing community perspectives.

      published: 10 Apr 2019
    • Idiopathic Pulmonary Fibrosis: The Simple Facts

      This simple video presents a basic understanding of idiopathic pulmonary fibrosis (IPF). This fatal condition does not have a known cause, and research investigating its pathology is ongoing. Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/DemystifyingMedicine This video is provided for general and educational information only. Please consult your health care provider for Information about your health. This video was made by McMaster students Adrienne Lee, Kim Rod, Patrick Rudak, Ria Oommen and Shylendra Mahendran, in an effort to increase awareness and understanding about IPF, in collaboration with the McMaster Demystifying Medicine Program © 2015. McMaster University. #DemystifyingMedicine, #IPF

      published: 16 May 2015
    • Breath of Awareness: Exploring Interstitial Lung Disease (ILD) | Interstitial Lung Disease podcast

      Interstitial Lung Disease (ILD) consists of various lung disorders that cause progressive scarring and inflammation of the lung tissue. This scarring of lung tissue can result in difficulty breathing and impair oxygen supply to the bloodstream, making it critical for daily activities. With over 200 different types of ILD, including idiopathic pulmonary fibrosis and sarcoidosis, understanding this condition can be distressing. In this episode of the Interstitial Lung Disease (ILD) podcast, we will explore this complex and most often misunderstood condition, which has symptoms similar to those of other lung disorders, such as breathlessness and chest tightness. Join the PACE Hospitals Podcast with Dr. Pradeep Kiran Panchadi, Consultant Interventional Pulmonologist and specialist in Broncho...

      published: 04 Jul 2024
    • Managing idiopathic pulmonary fibrosis

      Idiopathic pulmonary fibrosis is a slowly progressive disease that causes the lungs to fill with scar tissue. Dr. Andrew Limper, a pulmonary and critical care medicine physician, talks about the advantages of coming to Mayo Clinic for treatment.

      published: 07 Dec 2012
    • Behind Each Breath: Shedding Light on Idiopathic Pulmonary Fibrosis

      Learn more about Idiopathic Pulmonary Fibrosis (IPF) here: https://www.gene.com/stories/behind-each-breath-shedding-light-on-idiopathic-pulmonary-fibrosis

      published: 08 Sep 2020
    • Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults

      This American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior idiopathic pulmonary fibrosis (IPF) guidelines and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. Read the guidelines here: https://www.atsjournals.org/doi/full/10.1164/rccm.202202-0399ST

      published: 12 Sep 2022
    Idiopathic Pulmonary Fibrosis - pathophysiology, signs and symptoms, investigation and treatment
    11:06

    Idiopathic Pulmonary Fibrosis - pathophysiology, signs and symptoms, investigation and treatment

    • Order:
    • Duration: 11:06
    • Uploaded Date: 21 Aug 2021
    • views: 123017
    "Idiopathic pulmonary fibrosis is a chronic progressive fibrotic interstitial lung disease of unknown cause that primarily occurs in older adults. Doctors suspect interstitial lung disease when an adult presents with unexplained exertional dyspnoea, chronic dry cough or inspiratory velcro-like crackles on examination. Fibrosis is typically in the lower lobes of the lung. Clubbing , low oxygen saturation and dyspnoea is the hallmark of idiopathic pulmonary fibrosis. High resolution CT chest is cold standard for diagnosis. Here you see the pathological pattern of usual interstitial pneumonia: low base predominance, traction bronchiectasis, honeycombing and reticular changes without significance ground glass changes" Support me: 🖼️ Buy PDFs: http://armandoh.org/shop 💵 Patreon: http://www.patreon.com/armando 👕 Buy shirts: https://teespring.com/stores/ah-7 Social media: 📷 Instagram: http://instagram.com/armandohasudungan 🐦 Twitter: https://twitter.com/armandohasudung 📔 Facebook: https://www.facebook.com/ArmandoHasudungan Resources: 📕 Books: http://armandoh.org/resource 🎞️ Equipment: armandoh.org/armando-faigl You can send me mail: 📫 PO BOX 166, Randwick NSW 2031, Australia
    https://wn.com/Idiopathic_Pulmonary_Fibrosis_Pathophysiology,_Signs_And_Symptoms,_Investigation_And_Treatment
    Idiopathic Pulmonary Fibrosis | Restrictive Lung Disease | Pulmonology
    11:01

    Idiopathic Pulmonary Fibrosis | Restrictive Lung Disease | Pulmonology

    • Order:
    • Duration: 11:01
    • Uploaded Date: 26 Sep 2019
    • views: 92238
    😍🖼Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/ - With Picmonic, get your life back by studying less and remembering more. Medical and Nursing students say that Picmonic is the most comprehensive and effective way to bridge learning and test prep... Disclaimer: I use affiliate links.... ►👨‍🏫💊Antibiotics Lectures: https://www.medicosisperfectionalis.com/products/courses/antibiotics/ ... Check out my brand new "Electrolytes" course at https://www.medicosisperfectionalis.com/products/course/electrolytes/ and use the PROMO code: ELECTROLYTES50 to get a 50% discount. If you like my videos, please consider leaving a tip at https://www.paypal.me/perfectionalis/ ► Visit my website: https://www.medicosisperfectionalis.com/ My Favorite Productivity App: https://airtable.com/invite/r/2zH40fus/ 📱Save on your mobile phone bill: http://fbuy.me/q6bMj 🏦 Qbank (TrueLearn): https://truelearn.referralrock.com/l/MEDICOSIS/
    https://wn.com/Idiopathic_Pulmonary_Fibrosis_|_Restrictive_Lung_Disease_|_Pulmonology
    Signs & Symptoms of Idiopathic Pulmonary Fibrosis (IPF)
    1:07

    Signs & Symptoms of Idiopathic Pulmonary Fibrosis (IPF)

    • Order:
    • Duration: 1:07
    • Uploaded Date: 07 Sep 2017
    • views: 9631
    https://wn.com/Signs_Symptoms_Of_Idiopathic_Pulmonary_Fibrosis_(Ipf)
    Introduction into idiopathic pulmonary fibrosis (IPF)
    1:13

    Introduction into idiopathic pulmonary fibrosis (IPF)

    • Order:
    • Duration: 1:13
    • Uploaded Date: 29 Nov 2016
    • views: 41660
    Idiopathic pulmonary fibrosis (or IPF) is a life-threatening lung disease. The pathophysiology of this condition is not fully understood, though it is believed to arise through successive injury to the alveolar epithelial cell compartment.
    https://wn.com/Introduction_Into_Idiopathic_Pulmonary_Fibrosis_(Ipf)
    Idiopathic Pulmonary Fibrosis: Bills Story
    3:53

    Idiopathic Pulmonary Fibrosis: Bills Story

    • Order:
    • Duration: 3:53
    • Uploaded Date: 10 Apr 2019
    • views: 9845
    Bill Van Nierop, who lives with Idiopathic Pulmonary Fibrosis (IPF), defines himself as an IPF patient not an IPF sufferer. Bill talks about the stigma surrounding lung disease, the impact this has on research and his goal to to help others living with a lung disease through raising awareness and changing community perspectives.
    https://wn.com/Idiopathic_Pulmonary_Fibrosis_Bills_Story
    Idiopathic Pulmonary Fibrosis: The Simple Facts
    4:43

    Idiopathic Pulmonary Fibrosis: The Simple Facts

    • Order:
    • Duration: 4:43
    • Uploaded Date: 16 May 2015
    • views: 80071
    This simple video presents a basic understanding of idiopathic pulmonary fibrosis (IPF). This fatal condition does not have a known cause, and research investigating its pathology is ongoing. Subscribe to the McMaster Demystifying Medicine YouTube channel: https://www.youtube.com/c/DemystifyingMedicine This video is provided for general and educational information only. Please consult your health care provider for Information about your health. This video was made by McMaster students Adrienne Lee, Kim Rod, Patrick Rudak, Ria Oommen and Shylendra Mahendran, in an effort to increase awareness and understanding about IPF, in collaboration with the McMaster Demystifying Medicine Program © 2015. McMaster University. #DemystifyingMedicine, #IPF
    https://wn.com/Idiopathic_Pulmonary_Fibrosis_The_Simple_Facts
    Breath of Awareness: Exploring Interstitial Lung Disease (ILD) | Interstitial Lung Disease podcast
    17:45

    Breath of Awareness: Exploring Interstitial Lung Disease (ILD) | Interstitial Lung Disease podcast

    • Order:
    • Duration: 17:45
    • Uploaded Date: 04 Jul 2024
    • views: 65
    Interstitial Lung Disease (ILD) consists of various lung disorders that cause progressive scarring and inflammation of the lung tissue. This scarring of lung tissue can result in difficulty breathing and impair oxygen supply to the bloodstream, making it critical for daily activities. With over 200 different types of ILD, including idiopathic pulmonary fibrosis and sarcoidosis, understanding this condition can be distressing. In this episode of the Interstitial Lung Disease (ILD) podcast, we will explore this complex and most often misunderstood condition, which has symptoms similar to those of other lung disorders, such as breathlessness and chest tightness. Join the PACE Hospitals Podcast with Dr. Pradeep Kiran Panchadi, Consultant Interventional Pulmonologist and specialist in Bronchoscopy and EBUS at PACE Hospitals, Hitech City, Hyderabad, India, to learn about Interstitial Lung Disease (ILD). 👇 Chapters of Interstitial Lung Disease (ILD) podcast 00:40 What is Interstitial lung disease? 04:36 What exactly causes of Interstitial lung disease? 07:01 How do we classify Interstitial lung disease? 08:04 How is ILD diagnosed? What are the various diagnostic methods? 13:00 How is Interstitial lung disease treated? 15:28 What are the complication of Interstitial lung disease? Dr. Pradeep Kiran Panchadi - Interventional Pulmonologist, Specialist in Bronchoscopy and EBUS https://www.pacehospital.com/dr-pradeep-kiran-panchadi PACE Hospitals Podcast - Health and Wellness Podcasts: https://www.pacehospital.com/podcast Breath of Awareness: Exploring Interstitial Lung Disease (ILD): https://www.pacehospital.com/com/podcast/interstitial-lung-disease-podcast Interstitial Lung Disease - Causes, Symptoms and Treatment: https://www.pacehospital.com/interstitial-lung-disease-causes-symptoms-and-treatment #Interstitiallungdisease #Interstitiallungdiseasepodcast #ILDpodcast #lungdisease #pulmonologypodcast #lungdisorderpodcast #lungs #lunghealth #healthpodcast #Pulmonologist #pulmonology #Pacehospitalspodcast #pacehospitals #hyderabad #india PACE Hospitals Hitech City and Madinaguda, Hyderabad, Telangana, India T: 04048486868 https://www.pacehospital.com/ Follow us: Facebook - https://www.facebook.com/PaceHospitals Instagram - https://www.instagram.com/pacehospitals/ Google - https://g.page/pacehospitals LinkedIn - https://www.linkedin.com/in/pace-hospitals-11716956/ Twitter - https://twitter.com/PACEHospitals Reddit - https://www.reddit.com/u/Pacehospital Quora - https://www.quora.com/profile/Pace-Hospitals-2 Related: Interstitial Lung Disease, ILD, lung disorder, lung disease, Interstitial Lung Disease awareness, ILD awareness, Interstitial Lung Disease podcast, ILD podcast, pulmonology podcast, lung disease podcast, disease podcast, health podcast, digital health, digital healthcare, digital health solutions, digital health solutions, Health and Wellness podcast, wellness podcasts, Patient Care podcast, medical podcast, digital health podcasts, healthcare podcast, pulmonology, pulmonologist, PACE Hospitals podcast
    https://wn.com/Breath_Of_Awareness_Exploring_Interstitial_Lung_Disease_(Ild)_|_Interstitial_Lung_Disease_Podcast
    Managing idiopathic pulmonary fibrosis
    4:28

    Managing idiopathic pulmonary fibrosis

    • Order:
    • Duration: 4:28
    • Uploaded Date: 07 Dec 2012
    • views: 28955
    Idiopathic pulmonary fibrosis is a slowly progressive disease that causes the lungs to fill with scar tissue. Dr. Andrew Limper, a pulmonary and critical care medicine physician, talks about the advantages of coming to Mayo Clinic for treatment.
    https://wn.com/Managing_Idiopathic_Pulmonary_Fibrosis
    Behind Each Breath: Shedding Light on Idiopathic Pulmonary Fibrosis
    2:17

    Behind Each Breath: Shedding Light on Idiopathic Pulmonary Fibrosis

    • Order:
    • Duration: 2:17
    • Uploaded Date: 08 Sep 2020
    • views: 16160
    Learn more about Idiopathic Pulmonary Fibrosis (IPF) here: https://www.gene.com/stories/behind-each-breath-shedding-light-on-idiopathic-pulmonary-fibrosis
    https://wn.com/Behind_Each_Breath_Shedding_Light_On_Idiopathic_Pulmonary_Fibrosis
    Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
    3:16

    Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults

    • Order:
    • Duration: 3:16
    • Uploaded Date: 12 Sep 2022
    • views: 4751
    This American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior idiopathic pulmonary fibrosis (IPF) guidelines and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. Read the guidelines here: https://www.atsjournals.org/doi/full/10.1164/rccm.202202-0399ST
    https://wn.com/Idiopathic_Pulmonary_Fibrosis_(An_Update)_And_Progressive_Pulmonary_Fibrosis_In_Adults
    PLAYLIST TIME:
    • Most Related
    • Most Recent
    • Most Popular
    • Top Rated
    PLAYLIST TIME: 0:00 / 1:00:49

    Idiopathic Pulmonary Fibrosis - pathophysiology, signs and symptoms, investigation and treatment

    "Idiopathic pulmonary fibrosis is a chronic progressive fibrotic interstitial lung disease of unknown cause that primarily occurs in older adults. Doctors suspect interstitial lung disease when an adult presents with unexplained exertional dyspnoea, chronic dry cough or inspiratory velcro-like crackles on examination. Fibrosis is typically in the lower lobes of the lung. Clubbing , low oxygen saturation and dyspnoea is the hallmark of idiopathic pulmonary fibrosis. High resolution CT chest is cold standard for diagnosis. Here you see the pathological pattern of usual interstitial pneumonia: low base predominance, traction bronchiectasis, honeycombing and reticular changes without significance ground glass changes" Support me: 🖼️ Buy PDFs: http://armandoh.org/shop 💵 Patreon: http://www.patreon.com/armando 👕 Buy shirts: https://teespring.com/stores/ah-7 Social media: 📷 Instagram: http://instagram.com/armandohasudungan 🐦 Twitter: https://twitter.com/armandohasudung 📔 Facebook: https://www.facebook.com/ArmandoHasudungan Resources: 📕 Books: http://armandoh.org/resource 🎞️ Equipment: armandoh.org/armando-faigl You can send me mail: 📫 PO BOX 166, Randwick NSW 2031, Australia
    11:06
    Idiopathic Pulmonary Fibrosis - pathophysiology, signs and symptoms, investigation and treatment
    "Idiopathic pulmonary fibrosis is a chronic progressive fibrotic interstitial lung disease...
    published: 21 Aug 2021
    Play in Full Screen
    11:01
    Idiopathic Pulmonary Fibrosis | Restrictive Lung Disease | Pulmonology
    😍🖼Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/ - With Pi...
    published: 26 Sep 2019
    Play in Full Screen
    1:07
    Signs & Symptoms of Idiopathic Pulmonary Fibrosis (IPF)
    published: 07 Sep 2017
    Play in Full Screen
    1:13
    Introduction into idiopathic pulmonary fibrosis (IPF)
    Idiopathic pulmonary fibrosis (or IPF) is a life-threatening lung disease. The pathophysio...
    published: 29 Nov 2016
    Play in Full Screen
    3:53
    Idiopathic Pulmonary Fibrosis: Bills Story
    Bill Van Nierop, who lives with Idiopathic Pulmonary Fibrosis (IPF), defines himself as an...
    published: 10 Apr 2019
    Play in Full Screen
    4:43
    Idiopathic Pulmonary Fibrosis: The Simple Facts
    This simple video presents a basic understanding of idiopathic pulmonary fibrosis (IPF). T...
    published: 16 May 2015
    Play in Full Screen
    17:45
    Breath of Awareness: Exploring Interstitial Lung Disease (ILD) | Interstitial Lung Disease podcast
    Interstitial Lung Disease (ILD) consists of various lung disorders that cause progressive ...
    published: 04 Jul 2024
    Play in Full Screen
    4:28
    Managing idiopathic pulmonary fibrosis
    Idiopathic pulmonary fibrosis is a slowly progressive disease that causes the lungs to fil...
    published: 07 Dec 2012
    Play in Full Screen
    2:17
    Behind Each Breath: Shedding Light on Idiopathic Pulmonary Fibrosis
    Learn more about Idiopathic Pulmonary Fibrosis (IPF) here: https://www.gene.com/stories/be...
    published: 08 Sep 2020
    Play in Full Screen
    3:16
    Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
    This American Thoracic Society, European Respiratory Society, Japanese Respiratory Society...
    published: 12 Sep 2022
    Play in Full Screen

    Idiopathic pulmonary fibrosis

    Idiopathic pulmonary fibrosis (IPF) is a chronic and ultimately fatal disease characterized by a progressive decline in lung function. The term pulmonary fibrosis means scarring of lung tissue and is the cause of worsening dyspnea (shortness of breath). Fibrosis is usually associated with a poor prognosis.

    IPF belongs to a large group of more than 200 lung diseases known as interstitial lung diseases (ILDs), characterized by the involvement of lung interstitium. The interstitium, the tissue between the air sacs in the lung, is the primary site of injury in ILDs. However, these disorders frequently affect not only the interstitium, but also the airspaces, peripheral airways, and vessels. Lung tissue from people with IPF shows a characteristic histopathologic pattern known as usual interstitial pneumonia (UIP). UIP is therefore the pathologic counterpart of IPF. The term 'idiopathic' is used because the cause of pulmonary fibrosis is still unknown. IPF usually occurs in adult individuals of between 50 and 70 years of age, particularly those with a history of cigarette smoking, and affects more men than women. The diagnosis of IPF requires exclusion of other known causes of ILDs and the presence of a typical radiological pattern identified through high resolution computed tomography (HRCT). In the right clinical setting, it is possible to make the diagnosis of IPF by HRCT alone, obviating the need for surgical lung biopsy.

    '); } else { var query = elem.find('.keywords').html(); $.ajax({ context: elem, url: 'https://wn.com/api/upge/cheetah-search-adv/video', cache: true, data: { 'query': query }, dataType: 'jsonp', success: function(text) { if (text.length > 0) { video_id = text[0].id; elem.find('.player').html(''); } } }); } } var stopAllYouTubeVideos = function() { var iframes = document.querySelectorAll('iframe'); Array.prototype.forEach.call(iframes, function(iframe) { iframe.contentWindow.postMessage(JSON.stringify({ event: 'command', func: 'pauseVideo' }), '*'); }); } jQuery(function() { jQuery(".playVideo").live("click", function() { if(!$(this).hasClass("played")){ stopAllYouTubeVideos(); var elem = $(this); setTimeout(function(){ mouseOverMe(elem); }, 1000); } }); jQuery(".description_box .expandContent").live("click", function() { elem = $(this).parent().parent().parent().find('.descContent'); if(elem.height() > 51) { elem.css('height', '44px'); $(this).html('Show More '); }else{ elem.css('height', 'auto'); $(this).html('Hide '); } }); jQuery('.interview-play-off').click(function() { $(".interview-play-off").hide(); $(".interview-play").show(); $(".videoplayer-control-pause").click(); }); jQuery(".video-desc .show_author_videos").live("click", function() { query = $(this).attr('title'); container = $(this).parent().parent().parent().find('.video-author-thumbs'); $(this).parent().parent().parent().find('.video-author-thumbs').css('height', '220px'); jQuery.ajax({ url: '/api/upge/cheetah-photo-search/videoresults', data: {'query': query}, success: function(text) { if(!text) { text = i18n("No results"); } container.html(jQuery(text)); } }); }); }); // -->

    Latest News for: idiopathic pulmonary fibrosis

    Edit

    Chronic Cough Market Expected to rise, 2034 | Merck & Co, Kyorin Pharmaceuticals, NeRRe Therapeutics, ...

    GetNews 04 Mar 2025
    In March 2024, Seyltx acquired ifenprodil, following Phase II trials that demonstrated a reduction in cough count among patients with idiopathic pulmonary fibrosis (IPF) and chronic cough.
    Edit

    Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

    Nasdaq Globe Newswire 03 Mar 2025
    ... panel, Pliant has discontinued the BEACON-IPF Phase 2b trial evaluating bexotegrast in patients with idiopathic pulmonary fibrosis (IPF).
    Edit

    Bernie Williams Exclusive: Yankees Legend Talks Juan Soto Departure, Cody Bellinger Addition, Ending Title Drought

    Sportslens 03 Mar 2025
    Bernie Williams Exclusive ... 28. He has worked to raise awareness of interstitial lung diseases since 2001, when Williams’ father, Bernabe Sr., died of idiopathic pulmonary fibrosis ... To learn more about Tune In to Lung Health, click here. Q ... Q ... Q ... Q ... Q ... Q ... Q ... Q.
    Edit

    Trevi Therapeutics to Participate in Upcoming March Investor Conferences

    Longview News-Journal 27 Feb 2025
    ... with idiopathic pulmonary fibrosis (IPF) and refractory ....
    Edit

    ‘He never stopped loving boxing’: Petrolia resident, pro boxer Mark Weinman dies at 62

    Times Standard 27 Feb 2025
    “He loved to work with people. He loved to pass on his knowledge ... “He was a good guy ... (Contributed/Brian Christensen) ... “Yeah ... 8 from complications related to idiopathic pulmonary fibrosis, a respiratory ailment he had been diagnosed with 12 years prior ... .
    Edit

    Every Wrestler Who Has Jumped From WWE To AEW (& Vice Versa)

    What Culture 27 Feb 2025
    Spoiler alert. A lot of wrestlers have jumped from WWE to AEW and from All Elite back to the E since Tony Khan launched his own would-be competitor in early-2019 ... 2.0 ... AQA ... Brodie sadly passed away from idiopathic pulmonary fibrosis on 26 December 2020.
    Edit

    Trevi Therapeutics Completes Enrollment for Phase 2b CORAL Trial of Haduvio in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough

    PR Newswire 25 Feb 2025
    About Idiopathic Pulmonary Fibrosis Chronic CoughChronic cough is highly prevalent in IPF patients, impacting up to 85% of the IPF population ... fibrosis (IPF) and refractory chronic cough (RCC).
    Edit

    Interstitial Lung Disease Market Set to Grow Substantially Through 2032, DelveInsight Projects | J2H Biotech, ...

    GetNews 21 Feb 2025
    Topline results from the Phase III FIBRONEER-ILD study (NCT05321082) indicate that nerandomilast enhanced lung function in patients with progressive fibrosing interstitial lung diseases (PF-ILDs), excluding idiopathic pulmonary fibrosis (IPF).
    Edit

    Qureight core imaging platform deployed within Vicore Phase 2b ASPIRE study of buloxibutid for IPF

    Pharmiweb 20 Feb 2025
    Vicore Pharma Holding AB is a clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential in respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).
    Edit

    Interstitial Lung Disease Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

    GetNews 18 Feb 2025
    The FDA designated it as an orphan drug for idiopathic pulmonary fibrosis (IPF) in 2019 ... BMS 986278, a lysophosphatidic acid receptor antagonist (LPA1) is being developed by Bristol-Myers Squibb, the treatment of idiopathic pulmonary fibrosis.
    Edit

    Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis (Form 8-K) (Pliant Therapeutics Inc)

    Public Technologies 13 Feb 2025
    on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis ... data from the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis (IPF).
    Edit

    Boxer Mark Weinman, who returned to the ring after a 21-year layoff and won a ...

    Chatanooga Times Free Press 12 Feb 2025
    He was 62. Weinman, from the borough of Queens in New York City, died Feb ... Mark Weinman died of complications from idiopathic pulmonary fibrosis, a respiratory illness he was diagnosed with more than a decade earlier ... I mean, he fought everybody ... ....
    Edit

    Cough in Idiopathic Pulmonary Fibrosis (IPF) Epidemiology Market Forecast Research 2020-2034

    Nasdaq Globe Newswire 11 Feb 2025
    11, 2025 (GLOBE NEWSWIRE) -- The "Cough in Idiopathic Pulmonary Fibrosis (IPF) - ...
    ×